Physician profile
Lance M Feray
NPI 1962509414
$1,309.16
in general payments reported to CMS, 2019-2025
19 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $105 · 2021: $22.65 · 2022: $109 · 2023: $253 · 2024: $115 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $237.80 | 2019-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $210.15 | 2020-2023 | Jardiance, Emgality, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $205.98 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.91 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $105.19 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $102.15 | 2025 | |
| Exact Sciences Corporation | $80.20 | 2023-2024 | Cologuard Collection Kit |
| Allergan, INC. | $38.40 | 2020 | |
| Medtronic, INC. | $34.97 | 2025 | Intellis Adaptivestim |
| Amgen INC. | $26.82 | 2019 | |
| Phathom Pharmaceuticals, INC. | $23.75 | 2025 | Voquezna |
| Corcept Therapeutics | $19.89 | 2025 | Korlym |
| Astellas Pharma US INC | $19.33 | 2024 | Veozah |
| Genentech USA, INC. | $17.99 | 2019 | |
| Cipher Pharmaceuticals US LLC | $15.38 | 2025 | Natroba, Spinosad |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.71 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.09 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Feray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.